Name: Latest research reports of Ipca Laboratories Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Ipca Laboratories Ltd.
Rating: 5
Author: Motilal Oswal

Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

1719.4000 23.00 (1.36%)

NSE Jul 02, 2026 15:31 PM

New 52W High in past week

Volume: 172.5K

Ipca Laboratories Ltd.

14 Oct 2024

1719.40

1.36%

At an inflexion point

Buy: Ipca Laboratories Ltd.

Recommendation Target

Motilal Oswal

After three years of earnings deterioration, IPCA is well-poised to deliver strong earnings growth over FY24-27.

Ipca Laboratories Ltd. has an average target of 1793.75 from 4 brokers.